These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27083831)

  • 21. Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Smith LN; Miller PE; Felchle LM
    Am J Vet Res; 2010 Sep; 71(9):1055-61. PubMed ID: 20807145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a photocrosslinkable hydroxyethyl chitosan hydrogel as a potential drug release system for glaucoma surgery.
    Qiao X; Peng X; Qiao J; Jiang Z; Han B; Yang C; Liu W
    J Mater Sci Mater Med; 2017 Aug; 28(10):149. PubMed ID: 28831622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Switch to latanoprost monotherapy from combined treatment with beta-antagonist and other antiglaucoma agents in patients with glaucoma or ocular hypertension.
    Ito K; Goto R; Matsunaga K; Sugimoto K; Uji Y
    Jpn J Ophthalmol; 2004; 48(3):276-80. PubMed ID: 15175922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma.
    Rouland JF; Traverso CE; Stalmans I; Fekih LE; Delval L; Renault D; Baudouin C;
    Br J Ophthalmol; 2013 Feb; 97(2):196-200. PubMed ID: 23203707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses.
    Davidson HJ; Pinard CL; Keil SM; Brightman AH; Sargeant JM
    Vet Ther; 2002; 3(1):72-80. PubMed ID: 12050830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified chitosan thermosensitive hydrogel enables sustained and efficient anti-tumor therapy via intratumoral injection.
    Jiang Y; Meng X; Wu Z; Qi X
    Carbohydr Polym; 2016 Jun; 144():245-53. PubMed ID: 27083815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma.
    McKibbin M; Menage MJ
    Eye (Lond); 1999; 13 ( Pt 1)():31-4. PubMed ID: 10396380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
    Dubey V; Mohan P; Dangi JS; Kesavan K
    Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan-based thermosensitive hydrogel as a promising ocular drug delivery system: preparation, characterization, and in vivo evaluation.
    Chen X; Li X; Zhou Y; Wang X; Zhang Y; Fan Y; Huang Y; Liu Y
    J Biomater Appl; 2012 Nov; 27(4):391-402. PubMed ID: 21750179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication.
    Magacho L; Reis R; Shetty RK; Santos LC; Avila MP
    Ophthalmology; 2006 Mar; 113(3):442-5. PubMed ID: 16458964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
    Gagliuso DJ; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety assessment of subconjunctivally implanted devices containing latanoprost in Dutch-belted rabbits.
    Jessen BA; Shiue MH; Kaur H; Miller P; Leedle R; Guo H; Evans M
    J Ocul Pharmacol Ther; 2013; 29(6):574-85. PubMed ID: 23489175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy.
    Jain K; Kumar RS; Sood S; Dhyanandhan G
    Curr Drug Deliv; 2013 Oct; 10(5):493-9. PubMed ID: 23410069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of latanoprost on the corneal epithelial barrier function in glaucoma patients.
    Ishibashi T; Yokoi N; Ohtsuki M; Mori K; Komuro A; Kinoshita S
    Ophthalmologica; 2002; 216(5):351-4. PubMed ID: 12424402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment.
    Liu S; Han X; Liu H; Zhao Y; Li H; D Rupenthal I; Lv Z; Chen Y; Yang F; Ping Q; Pan Y; Hou D
    Drug Deliv; 2020 Dec; 27(1):652-661. PubMed ID: 32347126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
    Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
    J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit.
    Sjöquist B; Basu S; Byding P; Bergh K; Stjernschantz J
    Drug Metab Dispos; 1998 Aug; 26(8):745-54. PubMed ID: 9698288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.